Femasys (FEMY) Other Accumulated Expenses (2020 - 2026)
Femasys' (FEMY) quarterly Other Accumulated Expenses came in at $29836.0 in Q1 2026, down 13.31% YoY from $34418.0 in Q1 2025, and down 53.61% on a QoQ basis from $64320.0 in Q4 2025.
Femasys (FEMY) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
Femasys (FEMY) has 7 years of Other Accumulated Expenses data on file, last reported at $29836.0 in Q1 2026.
- Quarterly Other Accumulated Expenses fell 13.31% year-over-year to $29836.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $29836.0 (down 13.31% YoY) and the FY2025 annual result came in at $64320.0, down 14.83% from the prior year.
- Other Accumulated Expenses slipped to $29836.0 in Q1 2026, from $64320.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $104178.0 in Q3 2022 to a low of $7960.0 in Q3 2025.
- A 5-year average of $43983.6 and a median of $36037.0 in 2022 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2023 — Other Accumulated Expenses slumped 89.23% — and 2024, when it surged 473.03%.
- Tracing FEMY's Other Accumulated Expenses over 5 years: stood at $11197.0 in 2022, then advanced by 17.7% to $13179.0 in 2023, then surged by 473.03% to $75519.0 in 2024, then slipped by 14.83% to $64320.0 in 2025, then tumbled by 53.61% to $29836.0 in 2026.
- The last three Other Accumulated Expenses figures came in at $29836.0 (Q1 2026), $64320.0 (Q4 2025), and $7960.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Femasys | 9.97 Mn | 8.53 Mn | 189,391.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29,836.00 |
| Dec 31, 2025 | 64,320.00 |
| Sep 30, 2025 | 7,960.00 |
| Jun 30, 2025 | 35,616.00 |
| Mar 31, 2025 | 34,418.00 |
| Dec 31, 2024 | 75,519.00 |
| Sep 30, 2024 | 53,615.00 |
| Jun 30, 2024 | 58,050.00 |
| Mar 31, 2024 | 53,606.00 |
| Dec 31, 2023 | 13,179.00 |
| Sep 30, 2023 | 11,221.00 |
| Jun 30, 2023 | 21,501.00 |
| Mar 31, 2023 | 101,432.00 |
| Dec 31, 2022 | 11,197.00 |
| Sep 30, 2022 | 104,178.00 |
| Jun 30, 2022 | 36,037.00 |
| Mar 31, 2022 | 36,037.00 |
| Dec 31, 2021 | 100,765.00 |
| Sep 30, 2021 | 189,937.00 |
| Jun 30, 2021 | 32,895.00 |